Mirantus Health
Mirantus Health40About
What is Mirantus Health's revenue?
StartupHub estimates Mirantus Health's annual revenue at $11.3M (range $4.9M to $41.8M, 31% confidence), based on comparable companies in the sector.
What is Mirantus Health's valuation?
StartupHub estimates Mirantus Health's effective valuation at $225.7M (range $148.5M to $356.4M, 20% confidence), based on comparable companies in the sector.
How much funding has Mirantus Health raised?
Mirantus Health has raised a total of $59M in funding. The most recent round on record is Growth.
Where is Mirantus Health headquartered?
Mirantus Health is headquartered in San Francisco, United States.
When was Mirantus Health founded?
Mirantus Health was founded in 2021.
What industry does Mirantus Health operate in?
Mirantus Health operates in HealthTech, MedTech, Digital Health, Chronic Disease Management, Patient Engagement, AI-Driven Health.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.